Skip to main content
In stock | Hormonal Therapy

Buserelin

Oncology Type Solid Tumour (Prostate/Breast)
Drug Class / Mechanism LHRH Agonist
No Image
Description

Buserelin is classified as a LHRH Agonist, sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Hormonal Therapy
Oncology Type Solid Tumour (Prostate/Breast)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3